301 related articles for article (PubMed ID: 9196022)
1. The adenomatous polyposis coli (APC) tumor suppressor.
Polakis P
Biochim Biophys Acta; 1997 Jun; 1332(3):F127-47. PubMed ID: 9196022
[TBL] [Abstract][Full Text] [Related]
2. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
[TBL] [Abstract][Full Text] [Related]
3. A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo.
Hayashi S; Rubinfeld B; Souza B; Polakis P; Wieschaus E; Levine AJ
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):242-7. PubMed ID: 8990193
[TBL] [Abstract][Full Text] [Related]
4. Familial adenomatous polyposis: from bedside to benchside.
O'Sullivan MJ; McCarthy TV; Doyle CT
Am J Clin Pathol; 1998 May; 109(5):521-6. PubMed ID: 9576568
[TBL] [Abstract][Full Text] [Related]
5. Adenomatous polyposis coli (Apc) tumor suppressor gene as a multifunctional gene.
Senda T; Shimomura A; Iizuka-Kogo A
Anat Sci Int; 2005 Sep; 80(3):121-31. PubMed ID: 16158975
[TBL] [Abstract][Full Text] [Related]
6. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
7. Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene.
Rubinfeld B; Albert I; Porfiri E; Munemitsu S; Polakis P
Cancer Res; 1997 Oct; 57(20):4624-30. PubMed ID: 9377578
[TBL] [Abstract][Full Text] [Related]
8. Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.
Venesio T; Balsamo A; Scordamaglia A; Bertolaso M; Arrigoni A; Sprujevnik T; Rossini FP; Risio M
Mod Pathol; 2003 Jan; 16(1):57-65. PubMed ID: 12527714
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex.
Eklof Spink K; Fridman SG; Weis WI
EMBO J; 2001 Nov; 20(22):6203-12. PubMed ID: 11707392
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the APC gene and their implications for protein structure and function.
Polakis P
Curr Opin Genet Dev; 1995 Feb; 5(1):66-71. PubMed ID: 7749328
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in familial adenomatous polyps. Nuclear translocation of beta-catenin requires more than biallelic APC inactivation.
Bläker H; Scholten M; Sutter C; Otto HF; Penzel R
Am J Clin Pathol; 2003 Sep; 120(3):418-23. PubMed ID: 14502807
[TBL] [Abstract][Full Text] [Related]
12. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.
Abraham SC; Wu TT; Klimstra DS; Finn LS; Lee JH; Yeo CJ; Cameron JL; Hruban RH
Am J Pathol; 2001 Nov; 159(5):1619-27. PubMed ID: 11696422
[TBL] [Abstract][Full Text] [Related]
13. Biology of the adenomatous polyposis coli tumor suppressor.
Goss KH; Groden J
J Clin Oncol; 2000 May; 18(9):1967-79. PubMed ID: 10784639
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
van der Luijt RB; Tops CM; Vasen HF
Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
[TBL] [Abstract][Full Text] [Related]
15. Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.
Schneikert J; Vijaya Chandra SH; Ruppert JG; Ray S; Wenzel EM; Behrens J
PLoS One; 2013; 8(7):e68072. PubMed ID: 23840886
[TBL] [Abstract][Full Text] [Related]
16. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
Schneikert J; Ruppert JG; Behrens J; Wenzel EM
PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
[TBL] [Abstract][Full Text] [Related]
17. Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity.
Smits R; Hofland N; Edelmann W; Geugien M; Jagmohan-Changur S; Albuquerque C; Breukel C; Kucherlapati R; Kielman MF; Fodde R
Genes Chromosomes Cancer; 2000 Nov; 29(3):229-39. PubMed ID: 10992298
[TBL] [Abstract][Full Text] [Related]
18. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of E-APC, a novel Drosophila homologue of the tumour suppressor APC.
Hamada F; Murata Y; Nishida A; Fujita F; Tomoyasu Y; Nakamura M; Toyoshima K; Tabata T; Ueno N; Akiyama T
Genes Cells; 1999 Aug; 4(8):465-74. PubMed ID: 10526234
[TBL] [Abstract][Full Text] [Related]
20. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Hu PJ; Knoepp SM; Wu R; Cho KR
Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
